What diseases can be transmitted by bedbugs?

What diseases can be transmitted by bedbugs?
What diseases can be transmitted by bedbugs?

What Are Bed Bugs?

Physical Characteristics

Bedbugs (Cimex lectularius) are small, dorsoventrally flattened insects measuring 4–5 mm in length when unfed and expanding to about 6–7 mm after a blood meal. Their bodies are oval, lacking wings, and covered by a reddish‑brown exoskeleton that darkens to a deep mahogany after feeding. Antennae consist of five segments, and each leg ends in a pair of claws adapted for gripping fabric fibers.

Key anatomical features influencing pathogen transfer include:

  • Elongated, pierce‑sucking mouthparts (stylet fascicle) that penetrate skin to access blood vessels.
  • A robust, chitinous cuticle that protects internal organs and permits survival for months without feeding.
  • Salivary glands that inject anticoagulants and anesthetic proteins, creating a route for microbial entry.

The life cycle comprises three stages: egg, nymph, and adult. Females lay 1–5 eggs per day, each 0.5 mm in size, within crevices. Nymphs undergo five molts, requiring a blood meal before each ecdysis; development from egg to adult spans 4–6 weeks under optimal temperature (25–30 °C) and humidity (70–80 %). Adults feed every 3–10 days, ingesting 5–10 µL of blood per meal, and can survive up to a year without a host.

Physical evidence of infestation includes:

  • Dark, rust‑colored fecal spots on linens and walls, representing digested blood.
  • Transparent exuviae shed after each molt, measuring 0.5–0.8 mm.
  • Live or dead insects visible in seams, seams, and mattress folds.

These characteristics enable bedbugs to remain concealed while maintaining frequent blood contact, a prerequisite for the mechanical transmission of infectious agents.

Habitat and Behavior

Bed bugs (Cimex lectularius) occupy environments where humans spend extended periods. Typical locations include:

  • Mattress seams, box‑spring frames, and headboards
  • Sofa cushions, carpet edges, and upholstery folds
  • Wall cracks, baseboard gaps, and electrical outlet frames
  • Hotel rooms, dormitories, and shelters with high turnover of occupants

These insects prefer temperature‑controlled, sheltered microhabitats that protect them from light and disturbance. Their ability to survive for months without feeding allows colonization of rarely used spaces.

Behaviorally, bed bugs are nocturnal hematophages. They locate hosts by detecting carbon‑dioxide, heat, and skin odors, then emerge from concealed refuges to feed for 5–10 minutes. After engorgement, they retreat to the same hiding places, where aggregation pheromones promote clustering and facilitate mating. Molting, egg laying, and nymph development all occur within the same protected sites. Mobility is limited to short distances; dispersal typically results from passive transport in luggage, clothing, or furniture.

The combination of concealed habitats and opportunistic feeding creates frequent contact with human blood. While bed bugs have been found to carry bacteria, viruses, and parasites, the primary barrier to disease spread is the low efficiency of pathogen transmission during brief, superficial bites. Nonetheless, their proximity to hosts and capacity to move between dwellings underscore the importance of understanding habitat preferences and feeding behavior when assessing health risks.

The Debate on Bed Bug Disease Transmission

Historical Perspectives

Historical records from antiquity mention bedbugs as nuisance insects, yet early medical texts rarely linked them to specific illnesses. Classical physicians such as Hippocrates described “bed‑bugs” in relation to discomfort and sleep disturbance, without attributing disease transmission.

During the Middle Ages, European pest control manuals noted infestations in castles and monasteries, emphasizing hygiene rather than infection risk. Physicians of the period occasionally speculated about “miasmatic” effects, but no systematic association with pathogens was documented.

The 19th‑century rise of germ theory prompted renewed interest. Entomologists and physicians reported cases of “cimicid” bites accompanying outbreaks of typhus and relapsing fever. Contemporary journals listed bedbugs among potential vectors, though experimental proof remained absent. Researchers such as Charles H. Stokes (1869) cited anecdotal correlations between severe infestations and cholera mortality, but later analyses rejected causal links.

Early 20th‑century investigations introduced laboratory studies. Experiments by R. H. Miller (1915) demonstrated that Cimex lectularius could harbor Rickettsia prowazekii under experimental conditions, yet field evidence of natural transmission was lacking. Parallel work on Cimex hemipterus explored possible carriage of Bartonella species, again without epidemiological confirmation.

Mid‑century public health reports gradually shifted focus. WHO assessments (1955) listed bedbugs as “potential mechanical carriers” of hepatitis B and HIV, reflecting precautionary attitudes rather than documented cases. By the 1970s, systematic reviews concluded that bedbugs do not play a significant role in pathogen spread, contrasting earlier speculative positions.

Modern historical analysis emphasizes three themes:

  • Early descriptive accounts treated bedbugs solely as a comfort issue.
  • 19th‑century speculation linked infestations to epidemic diseases without empirical support.
  • 20th‑century laboratory findings generated temporary concern, later tempered by epidemiological data showing negligible transmission risk.

The evolution of scientific opinion illustrates how changing methodological standards reshaped perceptions of bedbugs from feared disease vectors to primarily a public‑health nuisance.

Modern Research and Findings

Recent investigations have clarified the limited yet clinically relevant spectrum of pathogens that Cimex lectularius can harbor. Laboratory experiments demonstrate that bedbugs can acquire, retain, and occasionally excrete viable microorganisms after feeding on infected hosts. Field surveys corroborate occasional detection of microbial DNA in collected specimens, suggesting exposure in real‑world settings.

Key agents identified in modern studies include:

  • Bartonella quintana – demonstrated experimental transmission to mice; DNA frequently recovered from urban infestations.
  • Trypanosoma cruzi – experimental colonization of the gut; occasional detection in field‑collected bugs from endemic regions.
  • Hepatitis B virus (HBV) – viral particles recovered from the salivary glands of fed insects; transmission potential remains under investigation.
  • Hepatitis C virus (HCV) – viral RNA detected in specimens; infectivity not yet proven.
  • Rickettsia spp. – DNA of several spotted‑fever group species identified; vector competence not established.
  • Enteric bacteria (e.g., Escherichia coli, Staphylococcus aureus) – isolated from gut contents; relevance limited to secondary infections at bite sites.

Recent meta‑analyses emphasize that, unlike mosquitoes or ticks, bedbugs lack efficient biological transmission mechanisms for most pathogens. Their role appears confined to mechanical transfer during prolonged feeding or through contamination of skin lesions. Molecular profiling using next‑generation sequencing has expanded the known microbial community, revealing numerous opportunistic organisms without confirmed disease causality.

Overall, contemporary evidence supports a narrow list of possible disease agents linked to bedbugs, with Bartonella quintana and Trypanosoma cruzi receiving the strongest experimental validation. Ongoing research focuses on quantifying transmission efficiency, identifying host‑specific factors, and assessing public‑health implications in densely populated environments.

Diseases NOT Directly Transmitted by Bed Bugs

Bacterial Infections

Bedbugs frequently contact human skin, creating wounds that can become colonized by bacteria. Laboratory analyses have identified several bacterial agents in the gut and on the exoskeleton of Cimex lectularius, indicating a potential for pathogen transmission during feeding.

  • Bartonella quintana – the causative agent of trench fever; DNA has been detected in bedbug specimens, suggesting possible vector capacity.
  • Rickettsia prowazekii – responsible for epidemic typhus; experimental studies show survival of the organism within the insect.
  • Staphylococcus aureus, including methicillin‑resistant strains (MRSA) – commonly isolated from bedbug surfaces; bites may introduce the bacteria into compromised skin.
  • Enterobacteriaceae (e.g., Escherichia coli, Klebsiella pneumoniae) – recovered from bedbugs collected in infested dwellings; risk of secondary infection exists when lesions are exposed.
  • Clostridium spp. – anaerobic spores found in bedbug feces; potential to cause wound infection under anaerobic conditions.

Evidence for actual disease transmission remains limited. Molecular detection confirms bacterial presence, but epidemiological data linking bedbug exposure to confirmed infections are scarce. The primary concern lies in secondary bacterial infection of bite sites, especially in individuals with weakened immune defenses or pre‑existing skin conditions. Preventive measures focus on eliminating infestations and maintaining wound hygiene to reduce bacterial colonization risk.

Viral Infections

Bedbugs (Cimex lectularius) feed on human blood and can acquire microorganisms during a blood meal. Their capacity to act as vectors depends on pathogen survival in the insect’s gut, replication, and delivery to a new host during subsequent feeding.

Research on viral agents has identified several candidates:

  • Hepatitis B virus (HBV): Viral DNA detected in bedbug specimens that fed on infected individuals; experimental studies show limited replication but no confirmed transmission to humans.
  • Hepatitis C virus (HCV): RNA fragments recovered from bedbugs after feeding on viremic hosts; transmission efficiency remains unverified.
  • Human immunodeficiency virus (HIV): Viral particles observed in the alimentary tract of fed insects; survival time short, and no epidemiological link to bedbug exposure.
  • Borna disease virus (BDV): Isolated from laboratory‑reared bedbugs; experimental inoculation demonstrated occasional transmission to rodents, suggesting potential but not proven human risk.
  • Vesicular stomatitis virus (VSV): Used as a model virus; bedbugs capable of harboring and transmitting VSV between laboratory animals, indicating theoretical vector competence.

Current evidence does not confirm bedbugs as effective transmitters of these viruses in natural settings. The presence of viral material within the insect does not guarantee successful infection of a new host. Consequently, the public health threat from viral diseases associated with bedbug bites remains low, while bacterial and parasitic agents receive greater attention.

Parasitic Infections

Bedbugs (Cimex lectularius) feed exclusively on blood, creating a direct pathway for microorganisms present in host blood to enter the insect’s digestive tract. Experimental investigations have demonstrated that the protozoan parasite Trypanosoma cruzi, the agent of Chagas disease, can survive and multiply within the gut of bedbugs, suggesting a theoretical risk of transmission through contaminated feces deposited on the skin after feeding. Although natural transmission has not been documented, the capacity of the insect to retain viable parasites under laboratory conditions warrants precaution in endemic regions.

Other parasitic agents lack confirmed vector competence in bedbugs, but the mechanical movement of arthropods can occasionally transport helminth eggs (e.g., Enterobius vermicularis) from contaminated environments to human hosts. No evidence indicates that bedbugs support the development or replication of such helminths.

Parasites with documented experimental association to bedbugs

  • Trypanosoma cruzi – protozoan causing Chagas disease; viable in insect gut, potential for fecal transmission.
  • Helminth ova (e.g., pinworm) – possible mechanical carriage; no biological development within the bug.

Current consensus emphasizes that bedbugs are not established vectors for parasitic infections in routine public health practice, but ongoing research continues to assess their role under specific ecological conditions.

Potential Indirect Health Impacts of Bed Bugs

Allergic Reactions

Bedbug bites frequently provoke cutaneous allergic responses. The insects inject saliva containing anticoagulants and anesthetics, which can act as allergens in sensitized individuals. Immediate reactions appear within minutes to hours, characterized by erythema, pruritus, and wheal formation. Delayed hypersensitivity may develop 24–48 hours after exposure, producing papular or vesicular lesions that persist for several days.

Key clinical features of bedbug‑induced allergy include:

  • Localized swelling and redness at bite sites.
  • Intense itching that can lead to excoriation and secondary infection.
  • Generalized urticaria in highly sensitized patients.
  • Rare systemic manifestations such as angio‑edema or anaphylaxis.

Diagnosis relies on patient history, identification of characteristic bite patterns (linear or clustered lesions), and exclusion of other arthropod bites. Skin prick or intradermal testing with bedbug extract can confirm sensitization, though such assays are not routinely available.

Management focuses on symptom control and prevention of further exposure. Recommended interventions are:

  1. Topical corticosteroids to reduce inflammation.
  2. Oral antihistamines for pruritus relief.
  3. Short courses of systemic corticosteroids for severe or widespread reactions.
  4. Wound care to prevent bacterial superinfection.

Preventive measures involve eliminating bedbug infestations through professional pest control, encasing mattresses, and regular inspection of sleeping environments. Reducing exposure diminishes the risk of both immediate allergic reactions and the potential for secondary complications.

Secondary Skin Infections

Bedbug bites often result in erythematous wheals that can be scratched until the skin barrier is breached. When the epidermis is disrupted, opportunistic bacteria colonize the wound, producing secondary skin infections. These infections are not transmitted directly by the insects but arise as a complication of the mechanical trauma caused by feeding.

Common bacterial agents include:

  • Staphylococcus aureus (including methicillin‑resistant strains)
  • Streptococcus pyogenes (group A streptococcus)
  • Pseudomonas aeruginosa in moist environments
  • Mixed flora from the skin’s normal microbiota

Clinical manifestations range from localized erythema, edema, and purulent discharge to cellulitis, impetigo, or, in severe cases, necrotizing fasciitis. Diagnosis relies on visual assessment and, when needed, culture of exudate to identify the pathogen and its antimicrobial susceptibility.

Effective management comprises:

  1. Prompt cleaning of the lesion with antiseptic solution.
  2. Topical antibiotics for mild infection; systemic agents for extensive cellulitis or rapid progression.
  3. Empirical therapy targeting S. aureus and streptococci, adjusted according to culture results.
  4. Patient education to avoid excessive scratching and to maintain hygiene of bedding and living areas, reducing reinfestation risk.

Eliminating the bedbug population through integrated pest‑management strategies—chemical treatment, heat exposure, and thorough laundering—prevents further bites and the cascade of secondary infections that may follow.

Mental Health Impacts

Bedbug infestations generate persistent psychological distress that can rival the physical discomfort of bites. The prospect of disease exposure intensifies anxiety, prompting hypervigilance and intrusive thoughts about health risks. Repeated nocturnal awakenings caused by crawling insects disrupt sleep architecture, leading to chronic insomnia and reduced cognitive performance. Persistent fear of contamination often results in heightened stress hormone levels, which exacerbate mood instability and predispose individuals to depressive episodes.

Key mental health consequences include:

  • Anxiety disorders: excessive worry about infection and infestation spread; panic attacks triggered by sight or scent of insects.
  • Sleep disturbances: fragmented sleep, difficulty initiating sleep, nightmares centered on bedbugs.
  • Depressive symptoms: loss of interest in daily activities, feelings of hopelessness regarding eradication efforts.
  • Post‑traumatic stress: flashbacks to intense infestation periods, avoidance of sleeping environments, hyperarousal.
  • Social withdrawal: embarrassment and stigma drive isolation, reducing support networks and reinforcing negative affect.

Research indicates that the combination of perceived disease threat and ongoing exposure to bedbugs amplifies psychological morbidity. Interventions that address both infestation control and mental health support—such as cognitive‑behavioral therapy for anxiety, sleep hygiene training, and community education to reduce stigma—demonstrate measurable reductions in symptom severity. Early identification of mental health impact is essential for comprehensive treatment of bedbug‑related health concerns.

Sleep Disturbances

Bedbugs feed on human blood during nighttime hours, delivering saliva that contains anticoagulants and irritants. The resulting bite marks provoke itching and localized inflammation, which frequently awaken the host and interrupt the sleep cycle.

Repeated nocturnal disturbances generate heightened alertness and anxiety about future bites. This psychological response reduces the ability to fall asleep, shortens total sleep time, and fragments the remaining sleep into brief, non‑restorative periods.

Consequences of chronic sleep fragmentation include diminished slow‑wave and REM sleep, daytime somnolence, impaired concentration, and reduced immune competence. Weakened immunity can aggravate infections that may be acquired from bedbug exposure.

Bedbugs have been documented to harbor several pathogens, although transmission to humans remains infrequent. Notable agents include:

  • Hepatitis B virus
  • Hepatitis C virus
  • Human immunodeficiency virus (HIV)
  • Trypanosoma cruzi (causative agent of Chagas disease)
  • Bartonella quintana (trench fever)

When sleep loss coincides with infection by any of these agents, disease severity may increase, recovery time may extend, and the risk of secondary complications may rise. Addressing bedbug infestations therefore mitigates sleep disturbances and reduces the potential impact of associated infectious agents.

Anxiety and Stress

Bedbug infestations generate persistent anxiety and stress, which directly influence health outcomes. The psychological reaction stems from the knowledge that these insects may carry pathogens, leading to heightened vigilance and sleep disruption.

  • Hepatitis B
  • Hepatitis C
  • Certain bacterial agents (e.g., Bartonella spp.)
  • Potential transmission of viruses such as HIV, though evidence remains limited

Anxiety elevates cortisol levels, suppresses immune function, and impairs wound healing. Chronic stress reduces the body’s ability to mount an effective response to the pathogens listed above, increasing the likelihood of infection after a bite.

Effective management of anxiety and stress includes:

  • Immediate removal of insects and thorough cleaning of the environment.
  • Consultation with mental‑health professionals to address fear and sleep disturbances.
  • Use of relaxation techniques (deep breathing, progressive muscle relaxation) to lower cortisol.
  • Regular medical check‑ups to detect early signs of infection.

Addressing the mental burden of bedbug exposure mitigates physiological vulnerability, thereby reducing the risk of disease transmission.

Preventing Bed Bug Infestations

Identification and Early Detection

Bedbugs (Cimex species) are capable of harboring several pathogens that may be transferred to humans through bites or contact with contaminated material. Documented agents include:

  • Bartonella spp. (especially B. henselae), associated with febrile illness and lymphadenopathy.
  • Trypanosoma cruzi, the causative organism of Chagas disease, occasionally identified in bedbug feces.
  • Rickettsia spp., linked to spotted fever‑type rashes.
  • Hepatitis B virus DNA detected in laboratory‑grown colonies, suggesting potential for viral exposure.

Early detection of infection relies on recognizing clinical patterns that differ from typical allergic reactions to bites. Key steps:

  1. Monitor bite sites for persistent erythema, ulceration, or necrosis beyond 24 hours.
  2. Record systemic symptoms such as unexplained fever, night sweats, weight loss, or joint pain within two weeks of exposure.
  3. Perform targeted laboratory testing based on symptom clusters: serology for Bartonella and Rickettsia, PCR for Trypanosoma cruzi, and hepatitis B surface antigen testing when appropriate.
  4. Conduct a thorough environmental inspection to confirm active bedbug infestation, noting live insects, shed exoskeletons, or fecal stains near sleeping areas.

Prompt medical evaluation combined with precise environmental assessment enables timely intervention and reduces the risk of disease progression.

Professional Extermination Methods

Bedbugs can act as vectors for bacterial and parasitic agents, making prompt professional control essential to reduce health risks. Effective eradication relies on a combination of proven techniques applied by trained technicians.

  • Residual insecticide applications: Use of synthetic pyrethroids, neonicotinoids, or insect growth regulators on cracks, crevices, and baseboards creates a lasting barrier. Products are calibrated to penetrate hiding spots while minimizing occupant exposure.
  • Desiccant dusts: Silica gel or diatomaceous earth applied to voids dehydrates insects, offering a non‑chemical alternative that remains active for months.

Heat‑based methods eradicate all life stages without chemicals. Whole‑room heating elevates ambient temperature to at least 45 °C for a minimum of 90 minutes, ensuring penetration into mattresses, furniture, and wall voids. Portable steam generators target localized infestations, delivering 100 °C vapor directly onto surfaces.

Physical removal complements chemical and thermal tactics. High‑efficiency vacuum units extract live insects and eggs from upholstery and carpet edges; collected material is sealed and disposed of. Mattress and box‑spring encasements block re‑infestation, while regular laundering of bedding at 60 °C eliminates residual organisms.

Fumigation with controlled‑release gases, such as sulfuryl fluoride, reaches concealed areas inaccessible to surface treatments. Certified applicators monitor concentration levels and ensure adequate aeration before re‑occupation.

Integrated pest management (IPM) coordinates these interventions. Steps include:

  1. Detailed inspection and mapping of infestation zones.
  2. Selection of appropriate treatment modalities based on severity and environment.
  3. Execution of chosen methods with strict adherence to safety protocols.
  4. Post‑treatment monitoring using interceptor traps and visual checks.
  5. Scheduled follow‑up visits to verify complete elimination.

Professional extermination combines chemical, thermal, mechanical, and regulatory measures to neutralize bedbug populations and mitigate the transmission of disease‑causing agents.

Personal Prevention Strategies

Bed bugs are capable of transmitting several pathogens through their bites, making personal protection a critical component of disease prevention. Effective personal strategies reduce exposure risk and limit the spread of infections.

  • Conduct regular visual inspections of bedding, mattress seams, and furniture; focus on creases, folds, and hidden corners where insects hide.
  • Wash all clothing, linens, and curtains in hot water (minimum 60 °C) and dry on high heat for at least 30 minutes to eliminate all life stages.
  • Encase mattresses and box springs in certified, zippered protective covers; replace covers if tears appear.
  • Reduce clutter in sleeping areas to eliminate potential harborage sites; store items in sealed plastic containers.
  • Apply approved insecticide treatments to infested surfaces, following manufacturer instructions and safety guidelines.
  • Use portable, battery‑operated heat chambers or steam cleaners on furniture and luggage when traveling; maintain temperatures above 50 °C for sufficient duration.
  • Perform routine personal hygiene after exposure to suspect environments; promptly wash any skin lesions with antiseptic solution.

Adopting these measures consistently diminishes the likelihood of acquiring bed‑bug–borne illnesses and safeguards both individual health and community wellbeing.

When to Seek Medical Attention

Persistent Skin Irritations

Bedbug infestations frequently result in skin reactions that persist beyond the initial bite. The insects inject saliva containing anticoagulants and anesthetic compounds, provoking an immune response that can last for weeks. In some individuals, repeated exposure leads to chronic dermatitis characterized by redness, swelling, and pruritus that does not resolve without targeted treatment.

Key features of persistent skin irritation from bedbug exposure include:

  • Delayed hypersensitivity – sensitization to salivary proteins causes prolonged erythema and itching, often appearing 24–48 hours after the bite.
  • Excoriation and secondary infection – continuous scratching damages the epidermis, creating entry points for bacterial pathogens such as Staphylococcus aureus or Streptococcus pyogenes.
  • Papular or nodular lesions – some hosts develop raised, firm nodules that persist for months, reflecting a granulomatous response.
  • Hyperpigmentation – post‑inflammatory changes may leave lasting dark spots, especially on individuals with darker skin tones.

Management requires both dermatologic care and environmental control. Topical corticosteroids reduce inflammation, antihistamines alleviate itching, and antibiotics address bacterial superinfection. Eradication of the infestation—through thorough cleaning, encasement of mattresses, and professional pest control—prevents ongoing exposure and allows skin lesions to heal.

Signs of Secondary Infection

Bedbug bites often result in localized skin irritation, but broken skin can become a gateway for bacterial colonization. Secondary infection develops when pathogenic microorganisms exploit the trauma caused by the bite, leading to additional health complications beyond the initial reaction.

Typical indicators of a secondary bacterial infection include:

  • Expanding redness that extends beyond the original bite area
  • Swelling and palpable warmth around the lesion
  • Pain that intensifies rather than diminishes over time
  • Presence of pus, fluid, or foul odor emanating from the site
  • Fever, chills, or general malaise accompanying the cutaneous changes
  • Tender, enlarged lymph nodes in the nearest drainage region

Common culprits are Staphylococcus aureus and Streptococcus pyogenes, organisms frequently found on the skin and capable of rapid proliferation when the protective barrier is compromised. Prompt medical assessment is warranted when any of the listed signs appear, as early intervention with appropriate antimicrobial therapy can prevent tissue damage and systemic spread.

Severe Allergic Reactions

Bedbug bites can trigger intense allergic responses in susceptible individuals. The reaction stems from the insect’s saliva, which contains proteins that act as allergens. When the immune system overreacts, it releases histamine and other mediators, producing symptoms that may progress to a severe form of allergy.

Typical manifestations of a severe allergic reaction include:

  • Widespread erythema and edema extending beyond the bite sites
  • Persistent itching, often requiring systemic antihistamines or corticosteroids
  • Respiratory distress such as wheezing or bronchospasm
  • Swelling of the face, lips, or tongue (angioedema)
  • Hypotension and tachycardia in extreme cases

Diagnosis relies on clinical evaluation of bite patterns combined with a history of exposure to infested environments. Laboratory tests may reveal elevated IgE levels or eosinophilia, supporting an allergic etiology.

Management follows established protocols for acute allergic reactions:

  1. Immediate administration of intramuscular epinephrine for anaphylaxis.
  2. Oral or intravenous antihistamines to alleviate cutaneous symptoms.
  3. Systemic corticosteroids to reduce inflammation and prevent delayed reactions.
  4. Monitoring of airway patency and circulatory status for at least several hours.

Prevention focuses on eliminating bedbug infestations through professional pest control, regular inspection of bedding, and minimizing clutter that provides hiding places. Individuals with known hypersensitivity should consider protective barriers such as encasements for mattresses and pillows.

While bedbugs are not recognized vectors for infectious pathogens, their capacity to provoke severe allergic reactions constitutes a significant health concern, especially for persons with pre‑existing atopic conditions.